Deritas 7.5 Tablet PR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Darifenacin (7.5mg)
Overview Deritas 7.5 Tablet PR
Overactive bladder is treated with Deritas 7.5mg PR tablets, a muscarinic receptor blocker. This medication alleviates symptoms such as urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and regimen. Deritas 7.5mg PR may be ingested with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Common side effects include constipation, headache, dry mouth, urinary tract infection, nausea, and dry nasal passages. Report any persistent or bothersome side effects to your doctor promptly; they can offer strategies for management. Before commencing treatment, disclose all other medications and pre-existing conditions to your doctor. Inform your physician if you are pregnant or nursing. Patients with severe hepatic impairment should not use this medication without consulting a doctor.
Primary Ingredients of Deritas 7.5 Tablet PR
No information provided. Therefore, no text can be rewritten.
Uses of Deritas 7.5 Tablet PR
Managing overactive bladder (OAB) symptoms
Major Benefits of Deritas 7.5 Tablet PR:
Follow your doctor's instructions or the product label for proper administration. Deritas 7.5 Tablet PR can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Deritas 7.5 Tablet PR:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Deritas 7.5 Tablet PR:
Follow your doctor's instructions or refer to the product label for dosage information. Deritas 7.5 mg Tablet PR can be administered with or without food, although consistent timing is recommended.
How Deritas 7.5 Tablet PR works:
Deritas 7.5mg tablets, a medication classified as an antimuscarinic agent, alleviates urinary symptoms by reducing bladder muscle spasms, thus controlling incontinence and the urge to urinate frequently.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Deritas 7.5 Tablet PR may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Deritas 7.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Deritas 7.5 Tablet PR while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Deritas 7.5 Tablet PR, which can induce side effects like dizziness, blurred vision, insomnia, or somnolence.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Deritas 7.5 Tablet PR without requiring a dosage change. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Deritas 7.5 mg tablets with careful monitoring. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Deritas 7.5 Tablet PR :
Should you forget a Deritas 7.5 Tablet PR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Deritas 7.5 Tablet PR
| Label | Value |
|---|---|
| Chemical Category | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
3,018 People bought this recently